[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UY35108A - Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable - Google Patents

Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable

Info

Publication number
UY35108A
UY35108A UY0001035108A UY35108A UY35108A UY 35108 A UY35108 A UY 35108A UY 0001035108 A UY0001035108 A UY 0001035108A UY 35108 A UY35108 A UY 35108A UY 35108 A UY35108 A UY 35108A
Authority
UY
Uruguay
Prior art keywords
synthesis
ivabradine
pharmaceutically acceptable
application
addition salts
Prior art date
Application number
UY0001035108A
Other languages
English (en)
Inventor
Frédéric Sanchez
José Lorenzo González
Maria Del Pilar Carranza
Aranda Maria Isabel Garcia
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of UY35108A publication Critical patent/UY35108A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/34—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by unsaturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)

Abstract

Procedimiento de síntesis del compuesto de fórmula (I) : (I) Aplicación en la síntesis de la ivabradina, de sus sales de adición a un ácido farmacé uticamente aceptable y de sus hidratos.
UY0001035108A 2012-11-08 2013-10-29 Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable UY35108A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1260576A FR2997696B1 (fr) 2012-11-08 2012-11-08 Nouveau procede de synthese du (2e)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
UY35108A true UY35108A (es) 2014-05-30

Family

ID=47598957

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035108A UY35108A (es) 2012-11-08 2013-10-29 Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable

Country Status (36)

Country Link
US (1) US8779122B2 (es)
EP (1) EP2730562B1 (es)
JP (2) JP6058519B2 (es)
KR (1) KR20140059731A (es)
CN (1) CN103804225B (es)
AR (1) AR093373A1 (es)
AU (1) AU2013245452C1 (es)
BR (1) BR102013028259A2 (es)
CA (1) CA2831289C (es)
CY (1) CY1116253T1 (es)
DK (1) DK2730562T3 (es)
EA (1) EA027080B1 (es)
ES (1) ES2539618T3 (es)
FR (1) FR2997696B1 (es)
GE (1) GEP20156308B (es)
HK (2) HK1193408A1 (es)
HR (1) HRP20150570T1 (es)
HU (1) HUE026525T2 (es)
JO (1) JO3189B1 (es)
MA (1) MA35147B1 (es)
MD (1) MD4392C1 (es)
ME (1) ME02120B (es)
MX (1) MX355590B (es)
MY (1) MY159701A (es)
NZ (1) NZ616768A (es)
PL (1) PL2730562T3 (es)
PT (1) PT2730562E (es)
RS (1) RS53993B1 (es)
SA (1) SA113350005B1 (es)
SG (1) SG2013077235A (es)
SI (1) SI2730562T1 (es)
TW (1) TWI488833B (es)
UA (1) UA118008C2 (es)
UY (1) UY35108A (es)
WO (1) WO2014072640A1 (es)
ZA (1) ZA201308001B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN105541605A (zh) * 2016-02-04 2016-05-04 扬州大学 一种轴手性联萘配体前体(s)-2,2’-二羧酸-1,1’-联萘的合成方法
CN117838881A (zh) 2017-08-31 2024-04-09 第一三共株式会社 制备抗体-药物缀合物的新方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5310598B2 (es) * 1972-01-28 1978-04-14
JPH0753692B2 (ja) * 1990-10-30 1995-06-07 工業技術院長 芳香族カルボン酸エステル類の製造方法
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE4333711A1 (de) * 1993-10-02 1995-04-06 Hoechst Ag 2,4,5-Trihalogenzimtsäurenitrile und Verfahren zu ihrer Herstellung
DE10159270A1 (de) * 2001-12-03 2003-06-12 Bayer Ag Verfahren zur Arylierung von Olefinen
WO2005123662A1 (en) * 2004-06-18 2005-12-29 Janssen Pharmaceutica N.V. Modified heck reaction
CN101407474B (zh) * 2008-11-18 2011-12-14 东华大学 一种2-溴-4,5-二甲氧基苯丙腈的制备方法
JP5435127B2 (ja) 2010-05-06 2014-03-05 株式会社島津製作所 材料試験機
HUP1000245A2 (en) * 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
CN102464595B (zh) * 2010-11-17 2015-02-25 山东新时代药业有限公司 一种伊伐布雷定中间体的合成方法

Also Published As

Publication number Publication date
SG2013077235A (en) 2014-06-27
TW201418197A (zh) 2014-05-16
BR102013028259A2 (pt) 2014-10-07
SI2730562T1 (sl) 2015-07-31
AU2013245452B2 (en) 2017-02-16
MD20130082A2 (en) 2014-05-31
ES2539618T3 (es) 2015-07-02
JO3189B1 (ar) 2018-03-08
AU2013245452A1 (en) 2014-05-22
AR093373A1 (es) 2015-06-03
KR20140059731A (ko) 2014-05-16
JP2016047837A (ja) 2016-04-07
US8779122B2 (en) 2014-07-15
MD4392B1 (ro) 2016-01-31
JP6058519B2 (ja) 2017-01-11
CA2831289C (en) 2016-02-09
PL2730562T3 (pl) 2015-08-31
GEP20156308B (en) 2015-06-25
MD4392C1 (ro) 2016-08-31
MX2013012858A (es) 2014-08-07
ME02120B (me) 2015-10-20
CA2831289A1 (en) 2014-05-08
CY1116253T1 (el) 2017-02-08
HK1193408A1 (en) 2014-09-19
PT2730562E (pt) 2015-05-20
EA201301136A3 (ru) 2014-07-30
CN103804225B (zh) 2016-02-17
US20140128598A1 (en) 2014-05-08
HK1198159A1 (zh) 2015-03-13
RS53993B1 (en) 2015-10-30
FR2997696B1 (fr) 2014-12-05
HRP20150570T1 (en) 2015-07-03
EP2730562B1 (fr) 2015-03-25
AU2013245452C1 (en) 2017-06-22
EP2730562A1 (fr) 2014-05-14
JP2014114275A (ja) 2014-06-26
FR2997696A1 (fr) 2014-05-09
NZ616768A (en) 2015-02-27
EA027080B1 (ru) 2017-06-30
EA201301136A2 (ru) 2014-05-30
SA113350005B1 (ar) 2015-12-06
MY159701A (en) 2017-01-13
TWI488833B (zh) 2015-06-21
WO2014072640A1 (fr) 2014-05-15
MX355590B (es) 2018-04-24
DK2730562T3 (en) 2015-06-29
HUE026525T2 (en) 2016-06-28
MA35147B1 (fr) 2014-06-02
CN103804225A (zh) 2014-05-21
ZA201308001B (en) 2014-07-30
UA118008C2 (uk) 2018-11-12

Similar Documents

Publication Publication Date Title
PA8855501A1 (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
RS54873B1 (sr) Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
UY31883A (es) Nuevo procedimiento de síntesis de 7,8-dimetoxi-1, 3-dihidro-2h-3-benzazepin-2-ona, y aplicación en la síntesis de ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY32499A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY33893A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
UY32500A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY35108A (es) Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY34900A (es) Procedimiento de síntesis enzimática de la (7s)-1-(3,4-dimetoxibiciclo [4.2.0] octa-1,3,5-trien-7-il) n-metil metanamina, y aplicación a la síntesis de la ivabradina y de sus sales
UY34423A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY35561A (es) Procedimiento de síntesis del 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7- carbonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY35149A (es) Nuevo procedimiento de síntesis del 3 -(2-bromo-4,5-dimetoxifenil) propanonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY35068A (es) Nuevo procedimiento de síntesis del 3-(2-bromo-4,5-dimetoxifenil)propanonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY34685A (es) Nuevo procedimiento de síntesis de la ivabradinay de sus sales de adición a un ácido farmacéuticamente aceptable
UA111156C2 (uk) Спосіб синтезу івабрадину і його адитивних солей з фармацевтично прийнятною кислотою
UY35503A (es) Titulo: procedimiento de síntesis de derivados de la 7,8-dimetoxi-1,3 -dihidro-2h-3- benzazepin -2- ona y aplicación a la síntesis de la ivabradina
MX345518B (es) Compuestos analgesicos, metodos, y formulaciones.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210609